Due to the lack of enough blood samples, further studies should elucidate the effect of TLR2 activation on chemokine release of PBMCs from AD patients by ELISA, and phenotypic characterization of PBMCs could be done to better investigate the mechanism of AD. The gene discussed is TLR2; the disease is Alzheimer disease.